Nuclear medicine in cancer diagnosis
- 1 September 1999
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 354 (9181) , 853-857
- https://doi.org/10.1016/s0140-6736(99)80041-5
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- When to use bone scintigraphyPostgraduate Medicine, 1998
- Detection of extrathoracic metastases by positron emission tomography in lung cancerThe Annals of Thoracic Surgery, 1998
- Prospective investigation of positron emission tomography in lung nodules.Journal of Clinical Oncology, 1998
- Trials and tribulations: Oncological antibody imaging comes to the foreSeminars in Nuclear Medicine, 1997
- Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imagingEuropean Journal of Surgical Oncology, 1995
- F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer.Radiology, 1994
- Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.Radiology, 1994
- Whole-Body Positron Emission Tomography with 2-[18F]-Fluoro-2-deoxy-D-glucose Can Detect Recurrent Ovarian CarcinomaGynecologic Oncology, 1993
- Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.Radiology, 1992
- Somatostatin-Receptor Imaging in the Localization of Endocrine TumorsNew England Journal of Medicine, 1990